Interim guidance on the use of bivalent Omicron-containing COVID-19 vaccines for primary series. : HP5-158/1-2023E-PDF ; HP5-158/2-2023E-PDF
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.923285&sl=1
| Ministère/Organisme | Canada. National Advisory Committee on Immunization, issuing body. |
|---|---|
| Titre | Interim guidance on the use of bivalent Omicron-containing COVID-19 vaccines for primary series. |
| Variante du titre | Guidance on bivalent Omicron-containing COVID-19 vaccines for primary series |
| Type de publication | Monographie |
| Langue | [Anglais] |
| Autres langues publiées | [Français] |
| Format | Électronique |
| Document électronique |
|
| Note(s) | Issued also in French under title: Directives provisoires sur l'utilisation de vaccins bivalents contre la COVID-19 contenant Omicron dans le cadre d'une série primaire. Cover title. On cover: An Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI). "Pub.: 230092"--Verso of cover. "Pub.: 230094"--Verso of cover (summary). Includes bibliographical references (pages 15-19). |
| Information sur la publication | Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, 2023. ©2023 |
| Description | 1 online resource (19 pages) + summary (4 pages) |
| ISBN | 9780660489308 9780660489315 |
| Numéro de catalogue |
|
| Numéro de catalogue du ministère | 230092 230094 |
| Descripteurs | COVID-19 vaccines -- Canada. COVID-19 (Disease) -- Vaccination -- Canada. COVID-19 vaccines -- Government policy -- Canada. COVID-19 (Disease) -- Vaccination -- Government policy -- Canada. |